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Abstract
Introduction: Urorectal fistula (URF) is a devastating complica-
tion of pelvic cancer treatments and a surgical challenge for the 
reconstructive surgeon. We report a series of male patients with 
URF resulting from pelvic cancer treatments, specifically prostate 
(PCa), bladder (BCa), and rectal cancer (RCa), and explore the 
differences and impact on outcomes between purely surgical and 
non-surgical treatment modalities.
Methods: Between October 2008 and June 2015, 15 male patients, 
aged 59‒78 years (mean 67), with URF induced by pelvic cancer 
treatments were identified in our institutions. Patients with a history 
of diverticulitis, inflammatory bowel disease, or other benign con-
ditions were excluded. We reviewed the patients’ medical records 
for symptoms, diagnostic tests performed, type and etiology of the 
fistula, type of surgical reconstruction, followup, and outcomes.
Results: Fourteen patients underwent surgical reconstruction. One 
patient developed metastatic disease before URF repair and, there-
fore, was excluded from this study. Mean followup (FU) was 32.7 
months (14‒79). All patients received diverting colostomy and tem-
porary urinary diversion. An exclusively transperineal approach was 
used in nine (64.3%) patients and a combined abdominoperineal 
in five (35.7%). Overall successful URF closure was achieved in 12 
(85.7%) patients, nine (64.3%) of whom at the first reconstructive 
attempt, two (14.3%) after two attempts (in our institution), and one 
(7.1%) after three attempts (two of which elsewhere). An interposi-
tion flap was used in seven (50%) patients. Surgical reconstruction 
failed ultimately in two (14.3%) patients who still have a colostomy 
and do not wish any further reconstruction.
Conclusions: Our study has several limitations, including its retro-
spective nature and the heterogeneity of our small patient cohort. 
Nonetheless, although surgical reconstruction of URF may be 
extremely difficult and complex in the non-surgical/energy ablation 
patients, its successful reconstruction is possible in most through a 
transperineal, or a more aggressive abdominoperineal, approach 
with tissue interposition in selected patients.
Introduction 
Urorectal fistulae (URF) are a devastating complication of 
modern pelvic cancer treatments and are usually associ-
ated with debilitating morbidity and significant impact on 
quality of life (QoL). Despite its increasing incidence due 
to the expanding use of new energy ablation technology 
and new treatment protocols in pelvic cancer, URF remain 
relatively uncommon, their incidence varying widely from 
0.4‒3%;1,2 however, due to the adoption of these new thera-
peutic protocols for the current treatment of pelvic malignan-
cies, the complication paradigm has also changed, leading 
to a distinction between those resulting from purely surgical 
treatment and those following non-surgical, energy-ablative 
treatments, i.e., external beam radiotherapy (EBRT), brachy-
therapy (BT), high-intensity focused ultrasound (HIFU), cryo-
therapy, and a combination of these. Therefore, most URF 
have an iatrogenic etiology, resulting from surgery, radio-
therapy, or multimodal protocols, including salvage surgery, 
for the management of pelvic cancers.
Two distinct scenarios should be observed and discussed 
separately, as they portend two different outcomes in terms 
of treatment and prognosis: 1) URF associated with surgery 
(radical prostatectomy, radical cystectomy, transurethral 
resection, and rectal resection); and 2) URF secondary to 
non-surgical, energy-ablation treatments.2 The post-surgical 
URF patients are relatively easy to treat, with rapid recovery 
and return to daily routine activities. In contrast, URF patients 
following non-surgical treatments are more problematic and 
have a much slower return to a more compromised level of 
daily activities and overall recovery.1
Management of URF is challenging and often frustrating for 
the reconstructive surgeon. Spontaneous closure may rarely 
occur in very small fistulae not caused by irradiation and 
after fecal and urinary diversion.3,4 Therefore, failure of con-
servative treatment mandates surgical intervention. Several 
techniques have been employed for decades to treat URF, 
including transperineal, abdominoperineal, trans-ano-rectal 
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sphincter splitting (York-Mason), perianal rectal advancement 
flap (Parks), posterior transsacral (Kraske), and variants;1,5-8 
however, despite all these reported surgical possibilities, the 
single “best” procedure is still a topic of intense debate.
 We report a series of male patients with URF resulting 
from pelvic cancer treatments and explore the differences 
and impact on outcomes between purely surgical and non-
surgical treatment modalities, as well as drawing attention 
to the challenging nature of repair.
Methods
Patients
Between October 2008 and February 2015, we treated 14 
male patients with urorectal fistulae in our institutions. One 
patient following anterior rectal resection developed liver 
and lymph node metastases four months after URF diag-
nosis, while on antibiotic and conservative treatment of a 
pelvic infection/sepsis and, therefore, was excluded from 
this study. The patients’ medical records were retrospectively 
reviewed for demographic data, symptoms, fistula charac-
teristics, type of fistula repair, followup, and outcomes. All 
patients underwent digital rectal examination and flexible 
cystourethroscopy (Fig. 1). Retrograde urethrogram, pelvic 
computed tomography (CT) with 3D reconstruction, and 
magnetic resonance imaging (MRI) were also included in 
the routine preoperative assessment (Figs 2, 3). Two patients 
following anterior rectal resection received barium enema 
with fistulogram and rectosigmoidoscopy requested by their 
referring general/colorectal surgeons. Patients with fistulae 
due to benign causes were excluded.
All 14 patients presented urine leakage through the rec-
tum; however, fecaluria was noted by only four (28.5%) 
patients. In three patients treated with combined radiother-
apy and surgery, an infected pelvic cavity mandating surgi-
cal drainage and in-hospital parenteral antibiotic treatment 
was required. Three patients who received radiotherapy and 
HIFU presented with rectal, pelvic/perineal pain of varying 
degree and rectal bleeding.
Eight (57.1%) patients received some form of radiother-
apy, either EBRT or BT, or both, and in combination with 
surgery (anterior rectal resection, radical prostatectomy, 
transurethral resection of prostate [TURP] or of bladder 
tumor) or HIFU, and therefore were included in the group 
of URF induced by energy ablation (Group 1) (Table 1). In six 
(42.9%) patients, the etiology was purely surgical, i.e., open 
radical prostatectomy in two patients, laparoscopic radical 
prostatectomy in two, radical cystectomy and orthotopic 
urinary reconstruction in one, and anterior rectal resection 
in one (Group 2). The time interval between the development 
of the fistula and our urological observation varied between 
one and 15 months. Out of 12 patients whose fistula was 
successfully repaired, one had already had two previous 
failed surgical attempts (York-Mason followed by transaba-
dominal) and two patients had already been submitted to 
one failed attempt (York-Mason in both). In two (14.3%) 
patients, closure of the fistula tract was not possible and, 
therefore, these were considered surgical failures. One of 
these patients had received BT followed by EBRT and one 
had received HIFU and EBRT (Group 1). One of the URF 
patients after anterior rectal resection developed an associ-
ated urethroperineal fistula and underwent resection of his 
residual rectum because of local tumour recurrence.
Surgical repair
An exclusively transperineal approach was used in nine 
(64.3%) patients and a combined abdominoperineal 
approach in the remaining five (35.7%). The decision to 
opt for a combined abdominoperineal approach was based 
primarily on local tissue integrity/health, fistula character-
istics, and mainly, on radiation/energy ablation exposure. 
Interposition of vascularized flaps was used in seven (50.0%) 
patients, gracilis muscle (Fig. 4) in four patients, and omen-
tum in three. All patients had a diverting colostomy and 
urinary diversion (suprapubic cystostotomy or indwelling 
urethral catheterization) at the time of urological referral. 
Patients were placed in a slightly exagerated lithotomy posi-
tion and an inverted U incision was made with both ischial 
tuberosities as lateral limits and 2 cm below the scrotum as 
the upper limit. A 7 F ureteric guidewire was placed trans-
urethrally under endoscopic guidance whenever necessary 
or possible to facilitate fistula identification. Dissection com-
menced bilaterally through both ischiorectal fossa, develop-
Fig. 1. Cystourethroscopy of giant urorectal fistula located at the prostatic 
urethra and bladder neck.
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ing a plane to separate the anterior rectal wall from the ven-
tral aspect of the posterior urethra. In patients with prostate 
in place, the urinary side of the fistula was closed primarily 
at its urethral end followed, in some, by interposition of 
a vascularized flap. A simultaneous anastomotic posterior 
urethroplasty was needed in two patients. Two patients fol-
lowing RP (open and laparoscopic) required vesicourethral 
re-anastomosis, although this was also deemed necessary in 
a third patient, i.e., in one of the two patients who refused 
further reconstruction. The urinary side of the fistula was 
closed longitudinally in one plane and the rectal side was 
closed horizontally to maximize lumen circumference, in 
two planes whenever possible.
Both urinary and fecal diversions were always kept tem-
porarily after URF closure. A retrograde and voiding cysto-
urethrogram was performed 6‒8 weeks after reconstruction. 
Both indwelling urethral catheter and suprapubic cystos-
tomy were removed if there was no radiographic leak and 
the urethral healing appeared satisfactory endoscopically. 
Colostomy closure was recommended 4‒6 months after suc-
cessful URF closure.
The success of this reconstruction was defined as spon-
taneous urethral voiding without leakage from the rectum. 
Urinary incontinence after URF closure was not considered 
fistula reconstructive failure. All patients were previously 
informed about the possibility of further treatment for urinary 
incontinence.
Results 
Patient age ranged from 59‒78 years (mean 67). Patients were 
divided into two groups: Group 1 included eight (57.1%) 
patients who received energy-ablation treatments (EBRT, BT, 
or HIFU) as monotherapy or in combination with surgery, and 
Group 2 included six (42.9%) patients who had only surgery. 
Ten patients developed URF following treatment for prostate 
cancer (PCa): three patients after low-dose brachytherapy 
(LDB) combined with EBRT; five after radical prostatectomy 
(open in three patients and laparoscopic in two) with adjuvant 
EBRT in one of them; one patient after LDB followed by TURP 
due to prostatic obstruction; and one after combined HIFU 
and EBRT. Two patients developed URF after bladder cancer 
treatment (one after neoadjuvant chemotherapy plus radio-
therapy followed by TURBT and one after radical cystectomy 
and ileal neobladder), and two after anterior rectal resection 
(ARR), with adjuvant EBRT in  one (Table 2). No spontaneous 
fistula closure was observed in any patient.
Fourteen patients underwent URF surgical repair through 
a transperineal approach in nine and an abdominoperineal 
in five. Clinical characteristics of patients and surgical out-
comes of URF repair are summarized in Tables 2 and 3. 
Overall successful closure of the fistula was achieved in a 
total of 12 (85.7%) patients. Surgical reconstruction failed 
in two patients, who declined further surgery. Followup was 
available for all 14 patients and ranged from 14‒79 months 
(mean 32.7).
All patients developed some degree of urinary inconti-
nence (stress and mixed), probably multifactorial in origin, 
due to iatrogenic injury of the rabdosphincter and/or detru-
sor dysfunction, either because of direct surgical injury, or 
Fig. 2. Retrograde and voding cystourethrogram of a patient with urorectal fistula showing (A) the fistulous tract between bladder neck and rectum; and (B) the 
opening of the vesico-sigmoid fistulous tract above the bladder neck during bladder filling in a different patient.
Fig. 3. Magnetic resonance imaging of urorectal fistula between the prostatic 
urethra and rectum.
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because of irradiation/HIFU, or both. Of the six patients 
in Group 1 who underwent successful URF closure, an 
AMS800® artificial urinary sphincter was placed in three 
(one after RP + EBRT, one after BT + TURP, and one after 
ARR + EBRT). In Group 2, only one patient received an arti-
ficial urinary sphincter. The remainder tolerated their mild 
incontinence well under oral antimuscarinic treatment and 
with use of pads and, therefore, do not wish further surgery. 
All patients, including those who have an artificial urinary 
sphincter, wear 1‒2 pads daily for protection or hygiene 
reasons. All but two patients had their colostomy closed 
between four and six months after URF successful repair. 
Erectile dysfunction, varying from moderate to severe, 
was reported by all patients. 
Discussion 
URF following genitourinary and colorectal cancer treat-
ments are relatively uncommon, but a difficult reconstructive 
challenge for the surgeon. Furthermore, it carries a devas-
tating physical and psychological impact for the patient. 
Most URF have an iatrogenic origin, due to surgery, mostly 
associated with treatment of prostate cancer and, less com-
monly rectal and bladder cancers. With the exponential 
and widespread use of “minimally invasive” energy-abla-
tion treatments — supposedly less aggressive for the patient 
(especially to treat prostate cancer) — we have witnessed a 
significant increase in three types of vesicourethral compli-
cations in the last decades, which should be discussed in 
the same context. It is ironic that many of these patients are 
strongly advised to opt for less invasive and less aggressive 
treatment modalities to avoid surgery-related morbidity, and 
that some of them end up with much more devastating, cata-
strophic, incapacitating, and more-difficult-to-treat compli-
cations associated with these “minimally invasive” options.
Diagnosis of URF is relatively easy and obvious: urine 
loss through the rectum, which happened in all our patients. 
Although less commonly, some of our patients also com-
plained of pneumaturia and fecaluria. These symptoms 
denote a higher location of the fistula, usually vesico-rectal 
or vesico-sigmoid. Preoperative evaluation included cysto-
urethroscopy and retrograde/voiding cystourethrogram in all 
patients, and in two of them rectosigmoidoscopy and barium 
enema with fistulography. Although the two latter have diag-
nostic merits and, therefore, are requested preferentially by 
colorectal surgeons, urologists favour URF diagnosis on tests 
performed through the urinary tract due to higher familiar-
ity and, more importantly, because the pressure gradient 
in these fistulae is usually from the urinary to the intestinal 
side, except for fistulae of higher location. We think it is 
essential that these patients are assessed by pelvic MRI to 
better characterize the anatomy, location, and involvement 
of neighbouring structures.
Although some authors do not think colostomy before 
surgery to be critical, especially in URF of a purely surgi-
cal origin, we find it safe and prudent, particularly in low-
volume centres or for surgeons with limited experience and, 
therefore, we recommend it always.1,9-11 Others recommend 
a colostomy mainly in the radiation/energy-ablation setting 
due to more significantly impaired tissue conditions and 
to reduce inflammation.12 We could not avoid permanent 
fecal and urinary diversion in two patients after previously 
failed repairs due to the severely fibrotic local tissues and, 
consequently, extremely difficult reconstruction.
Spontaneous URF closure has been reported in the litera-
ture;3-5 however, no URF closed spontaneously in our series, 
although we admit that possibility in small, uncomplicated 
URF resulting from surgery.
In our series, to consent to surgery patients were informed 
that this type of reconstruction might eventually be a four-
stage procedure: creation of diverting colostomy (and simul-
taneous urinary diversion), URF closure, colostomy closure, 
and implantation of an artificial urinary sphincter.
We used a transperineal approach in most patients and 
an abdominoperineal approach in some. In nine (64.3%) 
patients, one single surgical repair was sufficient to close the 









Radical prostatectomy (open, laparoscopic)
Radical cystectomy (open)
Anterior rectal resection (open)
TURP: transurethral resection of prostate.
Fig. 4. Interposition of gracilis muscle flap in urorectal fistula repair: (A) 
surgical exposure of the perineal area; (B) harvesting of gracilis muscle; and 
(C) transposition of gracilis muscle into the perineum.
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URF successfully. An abdominoperineal approach was used 
in the five more difficult URF patients with dense pelvic tissue 
fibrosis, i.e., in four patients with history of previous energy 
ablation and in one patient following three reconstructive 
attempts, two of them elsewhere, to repair a URF caused by 
laparoscopic radical prostatectomy. Although we recognize 
merits and efficacy in other techniques described in the lit-
erature, we believe that the advantages of the transperineal 
approach are the following: effective separation between 
urinary tract and rectum, separate closure of both ends of 
fistula, possibility of vascularized flap interposition without 
the need of a second separate incision, possibility of a two-
plane, easier closure of the rectal side of the fistula, its feasi-
bility even after previously failed repair attempts and, finally, 
the possibility of performing this procedure in one stage only 
with no need for colostomy. The transperineal approach is 
usually favoured by urologists, who perform these operations 
themselves, as they feel more familiar with the perineal anat-
omy and with this “classical” urological approach to treat 
urological and other pelvic cancer complications involving 
the urinary tract.1 We think the transperineal approach is cur-
rently the most commonly used method for URF repair. On 
the other hand, in our opinion, access to the urinary tract is 
more difficult in the York-Mason procedure: 1) it cannot be 
used in large and complex fistulae; 2) it should be avoided 
in patients with severe radiation proctitis; 3) the operation is 
generally performed by general/colorectal surgeons; 4) the 
interposition of a vascularized flap requires a second inci-
sion; 5) the incidence of recto-cutaneous fistulation is higher; 
and 6) we do not see a reason for a risky and unnecessary 
division of the anal sphincter complex (both internal and 
external anal sphincters) with subsequent flatus incontinence 
and fecal soiling, although not true fecal incontinence.1,13-16 
This issue has been described superficially, insufficiently, or 
even ignored, in most York-Mason literature.6,11,17,18 Although 
popular between the 1960s and 1980s for the surgical treat-
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ARR: anterior resection of rectum; BN/LT: bladder neck/ low trigonal; EBRT: external beam radiotherapy; FU: followup; HIFU: high-intensity focused ultrasound; Lap RP: laparoscopic radical 
prostatectomy; M: months; RC: radical cystectomy; RRP: radical retropubic prostatectomy; TURP: transurethral resection of prostate.
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ment of small rectal cancers and adenomas, especially in 
an era where endoscopic excision of these lesions was non-
existent,6,18-20 its popularity has recently been replaced by the 
transperineal approach by reconstructive surgeons, especially 
in high-volume centres.9,12,21 
In our series, an abdominoperineal approach was reserved 
for patients that were complicated by the development of 
a cavity in association with energy ablation, such as EBRT, 
BT, and HIFU. Good surgical access via the perineum is, 
in most instances, hampered by unhealthy tissues, which 
are generally more difficult to mobilize and reach in depth. 
Moreover, in most of these patients, salvage procedures 
(e.g., salvage radical prostatectomy) and omental wrap are 
required to achieve satisfactory results. The two failures in 
our study were in the energy-ablation cohort and, although 
they underwent abdominoperineal approach, the fistula 
could not be closed successfully and thus, it was decided 
not to attempt any further.
Because the use of radiation or any other form of energy 
ablation adds complexity to URF repair and increases local 
morbidity, such as dense tissue fibrosis and associated ure-
thral and rectal strictures, pelvic cavitation and abscess, and 
pelvic/perineal and rectal pain, we think it is relevant to 
discuss iatrogenic URF in two distinct scenarios due to the 
therapeutic implications, success, and prognosis: 1) URF 
caused by surgery; and 2) URF resulting from non-surgical, 
energy-ablation-related iatrogeny, such as primary or adju-
vant EBRT, BT, cryotherapy, HIFU alone or in combination 
protocols. Globally, our surgical group patients were easier 
to treat, had less complications, and were associated with 
a shorter recovery and quicker return to their daily routine 
activities and bodily functions compared to the non-surgical 
group. All our surgical group patients were cured at the first 
surgical attempt. One such patient, however, needed three 
repair attempts, two of them elsewhere. Overall postopera-
tive success rate was 85.7% (12/14 patients); however, 100% 
success was achieved in Group 2 (6/6 patients) compared 
to 75% in Group 1 (6/8 patients) (Table 3). The two failures 
occurred in the Group 1 patients who had received heavy 
irradiation, combined with HIFU in one. These patients 
developed significant tissue fibrosis and devascularization, 
which prevent normal tissue healing, occasionally even 
with interposition of a vascularized flap, as shown by some 
authors.1,12,22 In our study, all patients in the non-surgical 
group received more than one therapeutic modality (Table 
2), stressing the concept of potentiation of deleterious and 
cumulative effects following irradiation.
In our series, mean followup of 32.7 months (14‒79) 
revealed no evidence of fistula recurrence in any of the 
successfully treated patients. Some degree of stress or mixed 
urinary incontinence was reported by all our patients; how-
ever, only four (28.5%) patients considered their inconti-
nence to be severe enough to necessitate insertion of an 
artificial urinary sphincter, with the remainder tolerating their 
incontinence well with help of antimuscarinic drugs and use 
of pads. Some patients admitted that, after such challeng-
ing repair, the wish to avoid further surgery coupled with 
burdensome convalescence was a reason for resignation.
Erectile dysfunction was similarly reported by all patients 
in our study. Interestingly, no patient has required surgical 
treatment, including placement of a penile prosthesis. Four 
patients in Group 2 and none in Group 1 have responded to 
oral PDE-5 inhibitors. Some authors have reported that pres-
ervation of potency, urinary incontinence, and rectal inner-
vation is possible after the York-Mason operation because it 
avoids dissection in the lateral pelvic and pararectal space.11 
We believe that in most URF patients, these complications 
result primarily from the oncological treatments that cause 
the fistula rather than the surgical repair.
Some authors have questioned the need for interposing 
vascularized flaps in URF repair.11 Although we have used 
tissue interposition in a total of seven (50%) patients, six 
of them after some form of energy ablation (Group 1), we, 
like others, do not think it is crucial to use it in URF caused 
exclusively by surgery, where tissue injury is less significant 
and extensive (except for a previously failed URF repair).12 
Therefore, we do not recommend the routine and indis-
criminate use of this adjuvant procedure, particularly in URF 
caused exclusively by surgical trauma; it should be used 
judiciously and with caution to avoid additional morbidity 
associated with these procedures. 
We recognize the limitations in our study, especially 
the retrospective nature of the analysis, the limited number 
of a heterogeneous cohort of patients rendering statistical 
analysis impossible, a complex learning curve, and the fact 
that all patients were operated on by the same surgeon, 
which may not necessarily be an advantage. We also are 
aware that the success rates tend to be naturally lower in less 
experienced hands and lower-volume centres;21 however, 
these limitations do not decrease the clinical importance 
Table 3. Surgical outcomes according to patient clinical characteristics
Patient groups Failures
Surgical success after X attempts Total Surgical approach Total Interposition flap
1 2 3 Perineal Abd-perineal Gracilis muscle Omentum
G1 (Non-
surgical)
2 4 2 0 8 4 4 8 3 3
G2 (Surgical) 0 5 0 1 6 5 1 6 1 0
Total 2 (14.3%) 9 (64.3%) 2 (14.3%) 1 (7.1%) 14 (100%) 9 (64.3%) 5 (35.7%) 14 (100%) 4/14 (28.5%) 3/14 (21.5%)
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of our data. In our study, mean followup is 32.7 months 
and only patients with followup ≥12 months were included, 
as some patients had their urinary diversion reversed and 
colostomy closed after 4‒6 months, which attests to the 
apparently definitive outcomes in our series. Moreover, we 
should stress the importance of the learning curve of this 
repair and, lastly, that the choice of the surgical approach 
should rely primarily on surgeon’s experience, preference 
and familiarity with a specific technique, as well as fistula 
and patient characteristics.
Conclusion 
Although increasing in incidence, iatrogenic URF remain an 
uncommon complication of pelvic cancer treatments with 
a devastating physical and psychological impact usually 
associated with incapacitating morbidity and deterioration 
of QoL. Its successful resolution is possible in most patients 
through a transperineal or an abdominoperineal approach 
with interposition of healthy, vascularized flaps, in select 
settings. When counselling patients about surgical vs. non-
surgical options as primary treatment for their pelvic cancer, 
the magnitude and complexity of complications, the ease of 
treatment of these complications, and the degree of return 
to normality are in favour of surgery.
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